News

"We show that if you can see where a virus is evolving ahead of time, you can begin to make future-proof vaccines," said first author Noor Youssef, a scientific lead for the Predictive Modeling for ...
The administration of the HPV nonavalent vaccine after surgical treatment leads to a substantial reduction in HPV recurrence among women with HPV-related cervical lesions.
A new research paper was published in Oncotarget , Volume 16, on April 24, 2025, titled "PD-L1 and FOXP3 expression in high-grade squamous intraepithelial lesions of the anogenital region." ...
HPV, short for human papillomavirus, is a common, sexually transmitted infection. The vaccine to prevent it has been around for almost 20 years now. Recent research from the Fred Hutchinson Cancer ...
The study discovered that previously unidentified HPV and human DNA enhancers increased the expression of tumor-promoting genes in cancer cells, leading to the production of more of the virus and ...
Having expertise in paediatric infectious diseases and vaccines, Dr Verma explained that the HPV infection was mostly transmitted through sexual contact. “The body often eliminates the virus ...
The virus particle is 200 nanometres in diameter, about twice the size of influenza or coronavirus. "Through an international collaboration, we elucidated the genome and structure of the ...
The study discovered that: Previously unidentified HPV and human DNA enhancers that increased the expression of tumor-promoting genes in cancer cells, leading to the production of more of the virus ...
In China alone, more than 33 million women have received the vaccination. HPV infection is a major challenge in global public health. According to the World Health Organization, approximately 80 ...
"HPV infection does not discriminate by gender. Men have a lower natural clearance rate of HPV infection compared to women and can also develop anal cancer, genital warts, and other diseases due to ...
This loss of protective function could facilitate HPV infection and persistence, a major risk factor for cervical cancer." "Our research shows that women who received praziquantel treatment ...